GPT and urinary bladder carcinoma: [365, 366] (QUILT‐2.005, NCT02138734) initially demonstrates that intravesical combination therapy with ALT‐803 for bladder cancer is both safe, without inducing systemic cytokine storms, and effective in achieving long‐term antitumor efficacy.